Location: Home
  • search
  • go
  • Relate News
  • 12/26/2024Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
  • 12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
  • 12/24/2024State Council Moves to Advance Pharma Reforms and Regulatory Streamlin...
  • 12/24/2024WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
  • 12/23/2024Sanofi Acquires Rights to Cytokinetics's Aficamten in Greater China
  • 12/23/2024MSD Finalizes Exclusive Global License Deal for Anti-PD-1 LM-299
  • 12/23/2024Roch Secures Chinese Approval of Lunsumio (Mosunetuzumab) for r/r Fol...
  • 12/23/2024RAPT Thera and Jemincare Enter License Deal for Novel Long-Acting an...
  • 12/20/2024China Licenses First Wholly Foreign-Owned Third-Grade General Hospital...
  • 12/20/2024Recent Executive Moves
  • 12/19/2024Palleon and Henlius Collaborate to Advance Glycan Editing for Autoimmu...
  • 12/19/2024BMS China Regains Rights to GPC3 Targeted Drug ABZ-706 in Greater Chin...
  • 12/18/2024Merck and Hansoh Enter into Global License Deal for Investigational Or...
  • 12/18/2024BMS and Fangzhou Forge Strategic Alliance to Advance Digital Healthcar...
  • 12/17/2024Eli Lilly's Alzheimer's Drug Donanemab Secures Approval in China
  • 12/16/2024Everest Medicines Announces Acceptance of the NDA for VELSIPITY
  • 12/16/2024Candid Therapeutics and EpimAb Biotherapeutics Enter Into Research Col...
  • 12/16/2024Mabwell Plans Hong Kong Dual Listing Amid Shifting Market Dynamics  
  • 12/16/2024Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China
  • 12/15/2024HUTCHMED Announces Breakthru Designation in China for ORPATHYS and TA...
  • 12/15/2024National Healthcare Security Work Conference Highlights Progress and S...
  • 12/13/2024RemeGen Unveils Phase III Study Results of Disitamab Vedotin in HER2-P...
  • 12/13/2024Recent Executive Moves
  • 12/12/2024Shanghai Unveils RMB10 Billion Biopharma M&A Fund to Drive Industry Gr...
  • 12/12/2024Bayer Co.Lab Expands in China with Three New Biotech Partners
  • 12/12/2024Chinese Generic Drug Market Expected to Rise at 10.70% CAGR During 202...
  • 12/12/2024JPO Publicizes the Proposed Results of the 10th National VBP
  • 12/11/2024South China Public Hospitals Slash Salaries Amid Mounting Financial Pr...
  • 12/11/2024Santhera Wins First Chinese Approval for Duchenne Muscular Dystrophy ...
  • 12/10/2024The Proposed BIOSECURE Act Faces Setback in Senate
  • Page:11/354 Total number of articles:10618: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group